Skip to main content
Top
Published in: Trials 1/2012

Open Access 01-12-2012 | Research

Use of randomisation in clinical trials: a survey of UK practice

Authors: Gladys C McPherson, Marion K Campbell, Diana R Elbourne

Published in: Trials | Issue 1/2012

Login to get access

Abstract

Background

In healthcare research the randomised controlled trial is seen as the gold standard because it ensures selection bias is minimised. However, there is uncertainty as to which is the most preferred method of randomisation in any given setting and to what extent more complex methods are actually being implemented in the field.

Methods

In this paper we describe the results of a survey of UK academics and publicly funded researchers to examine the extent of the use of various methods of randomisation in clinical trials.

Results

Trialists reported using simple randomisation, permuted blocks and stratification more often than more complex methods such as minimisation. Most trialists believed that simple randomisation is suitable for larger trials but there is a high probability of possible imbalance between treatment groups in small trials. It was thought that groups should be balanced at baseline to avoid imbalance and help face-validity. However, very few respondents considered that more complex methods offer any advantages.

Conclusions

This paper demonstrates that for most UK trialists the preferred method of randomisation is using permuted blocks of varying random length within strata. This method eliminates the problem of predictability while maintaining balance across combinations of factors. If the number of prognostic factors is large, then minimisation can be used to provide treatment balance as well as balance over these factors. However, only those factors known to affect outcome should be considered.
Appendix
Available only for authorised users
Literature
1.
go back to reference Roberts C, Torgerson D: Understanding controlled trials: randomisation methods in controlled trials. BMJ. 1998, 317: 1301-1310. 10.1136/bmj.317.7168.1301.CrossRefPubMedPubMedCentral Roberts C, Torgerson D: Understanding controlled trials: randomisation methods in controlled trials. BMJ. 1998, 317: 1301-1310. 10.1136/bmj.317.7168.1301.CrossRefPubMedPubMedCentral
2.
go back to reference Pocock SJ: Clinical Trials: A Practical Approach. 1983, Chichester: John Wiley & Sons Ltd Pocock SJ: Clinical Trials: A Practical Approach. 1983, Chichester: John Wiley & Sons Ltd
3.
go back to reference Begg CB, Iglewicz B: A treatment allocation procedure for sequential clinical trials. Biometrics. 1980, 36: 81-90. 10.2307/2530497.CrossRefPubMed Begg CB, Iglewicz B: A treatment allocation procedure for sequential clinical trials. Biometrics. 1980, 36: 81-90. 10.2307/2530497.CrossRefPubMed
4.
go back to reference Simon R: Restricted randomization designs in clinical trials. Biometrics. 1979, 35: 503-512. 10.2307/2530354.CrossRefPubMed Simon R: Restricted randomization designs in clinical trials. Biometrics. 1979, 35: 503-512. 10.2307/2530354.CrossRefPubMed
5.
go back to reference Assmann SF, Pocock SJ, Enos LE, Kasten LE: Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000, 355: 1064-1069. 10.1016/S0140-6736(00)02039-0.CrossRefPubMed Assmann SF, Pocock SJ, Enos LE, Kasten LE: Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000, 355: 1064-1069. 10.1016/S0140-6736(00)02039-0.CrossRefPubMed
8.
go back to reference Edwards P, Roberts I, Clarke M, DiGuiseppi C, Protop S, Kwan I: Methods to influence response rates to postal questionnaires. The Cochrane Library. 2007, 18 (2): MR000008- Edwards P, Roberts I, Clarke M, DiGuiseppi C, Protop S, Kwan I: Methods to influence response rates to postal questionnaires. The Cochrane Library. 2007, 18 (2): MR000008-
9.
go back to reference Therneau TM: How many stratification factors are 'too many' to use in a randomization plan?. Control Clin Trials. 1993, 14: 98-108. 10.1016/0197-2456(93)90013-4.CrossRefPubMed Therneau TM: How many stratification factors are 'too many' to use in a randomization plan?. Control Clin Trials. 1993, 14: 98-108. 10.1016/0197-2456(93)90013-4.CrossRefPubMed
10.
go back to reference Taves DR: Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther. 1974, 15: 443-453.CrossRefPubMed Taves DR: Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther. 1974, 15: 443-453.CrossRefPubMed
11.
go back to reference Atkinson AC: Optimum biased coin designs for sequential clinical trials with prognostic factors. Biometrics. 1982, 69: 61-67. 10.1093/biomet/69.1.61.CrossRef Atkinson AC: Optimum biased coin designs for sequential clinical trials with prognostic factors. Biometrics. 1982, 69: 61-67. 10.1093/biomet/69.1.61.CrossRef
12.
go back to reference Titterington DM: On constrained balance randomization for clinical trials. Biometrics. 1983, 39: 1083-1086. 10.2307/2531342.CrossRefPubMed Titterington DM: On constrained balance randomization for clinical trials. Biometrics. 1983, 39: 1083-1086. 10.2307/2531342.CrossRefPubMed
13.
go back to reference Signorini DF, Leung O, Simes RJ, Beller E, Gebski VJ: Dynamic balanced randomization for clinical trials. Stat Med. 1993, 12: 2343-2350. 10.1002/sim.4780122410.CrossRefPubMed Signorini DF, Leung O, Simes RJ, Beller E, Gebski VJ: Dynamic balanced randomization for clinical trials. Stat Med. 1993, 12: 2343-2350. 10.1002/sim.4780122410.CrossRefPubMed
14.
go back to reference Klotz JH: Maximum entropy constrained balance randomization for clinical trials. Biometrics. 1978, 34: 283-287. 10.2307/2530018.CrossRefPubMed Klotz JH: Maximum entropy constrained balance randomization for clinical trials. Biometrics. 1978, 34: 283-287. 10.2307/2530018.CrossRefPubMed
15.
go back to reference Campbell MK, McPherson G: Simple randomisation or minimisation: the impact of trial size [abstract]. Control Clin Trials. 2001, 22: 87S- Campbell MK, McPherson G: Simple randomisation or minimisation: the impact of trial size [abstract]. Control Clin Trials. 2001, 22: 87S-
16.
go back to reference Pocock SJ, Simon R: Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975, 31: 103-115. 10.2307/2529712.CrossRefPubMed Pocock SJ, Simon R: Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975, 31: 103-115. 10.2307/2529712.CrossRefPubMed
17.
go back to reference Lachin JM, Matts JP, Wei LJ: Randomization in clinical trials: conclusions and recommendations. Control Clin Trials. 1988, 9: 365-374. 10.1016/0197-2456(88)90049-9.CrossRefPubMed Lachin JM, Matts JP, Wei LJ: Randomization in clinical trials: conclusions and recommendations. Control Clin Trials. 1988, 9: 365-374. 10.1016/0197-2456(88)90049-9.CrossRefPubMed
18.
go back to reference Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. introduction and design. Br J Cancer. 1976, 34: 585-612. 10.1038/bjc.1976.220.CrossRefPubMedPubMedCentral Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. introduction and design. Br J Cancer. 1976, 34: 585-612. 10.1038/bjc.1976.220.CrossRefPubMedPubMedCentral
19.
go back to reference ICH Steering Committee: ICH Harmonised Tripartite Guideline E9; Statistical Principles for Clinical Trials. Stat Med. 1999, 18: 1905-1942. ICH Steering Committee: ICH Harmonised Tripartite Guideline E9; Statistical Principles for Clinical Trials. Stat Med. 1999, 18: 1905-1942.
20.
go back to reference Brown BW: Designing for cancer clinical trials: selection of prognostic factors. Cancer Treat Rep. 1980, 64: 499-502.PubMed Brown BW: Designing for cancer clinical trials: selection of prognostic factors. Cancer Treat Rep. 1980, 64: 499-502.PubMed
21.
go back to reference Armitage P, Gehan EA: Statistical methods for the identification and use of prognostic factors. Int J Cancer. 1974, 13: 36-CrossRef Armitage P, Gehan EA: Statistical methods for the identification and use of prognostic factors. Int J Cancer. 1974, 13: 36-CrossRef
22.
go back to reference Rovers MM, Straatman H, Zielhuis GA, Ingels K, van der Wilt G: Using a balancing procedure in multicenter clinical trials: simulation of patient allocation based on a trial of ventilation tubes for otitis media with effusion in infants. Int J Technol Assess Health Care. 2000, 16: 276-280. 10.1017/S0266462300161239.CrossRefPubMed Rovers MM, Straatman H, Zielhuis GA, Ingels K, van der Wilt G: Using a balancing procedure in multicenter clinical trials: simulation of patient allocation based on a trial of ventilation tubes for otitis media with effusion in infants. Int J Technol Assess Health Care. 2000, 16: 276-280. 10.1017/S0266462300161239.CrossRefPubMed
23.
go back to reference Committee for Proprietary Medicinal Products: Points to Consider on Adjustment for Baseline Covariates. 2003, London: European Medicines Evaluation Agency, 1-10. Committee for Proprietary Medicinal Products: Points to Consider on Adjustment for Baseline Covariates. 2003, London: European Medicines Evaluation Agency, 1-10.
24.
go back to reference Zielhuis GA, Straatman H, Hof-Grootenboer AE V'T, Van Lier HJJ, Rach GH, Van Der Broek P: The choice of a balanced allocation method for a clinical trial in otitis media with effusion. Stat Med. 1990, 9: 237-246. 10.1002/sim.4780090306.CrossRefPubMed Zielhuis GA, Straatman H, Hof-Grootenboer AE V'T, Van Lier HJJ, Rach GH, Van Der Broek P: The choice of a balanced allocation method for a clinical trial in otitis media with effusion. Stat Med. 1990, 9: 237-246. 10.1002/sim.4780090306.CrossRefPubMed
27.
go back to reference Forsythe AB, Stitt FW: Randomization or Minimization in the Treatment Assignment of Patient Trials: Validity and Power of Tests. 1977, Los Angeles, CA: Health Sciences Computing Facility, University of California Forsythe AB, Stitt FW: Randomization or Minimization in the Treatment Assignment of Patient Trials: Validity and Power of Tests. 1977, Los Angeles, CA: Health Sciences Computing Facility, University of California
28.
go back to reference Vaughan Reed J, Wickham EA: Practical experience of minimisation in clinical trials. Pharm Med. 1988, 3: 349-359. Vaughan Reed J, Wickham EA: Practical experience of minimisation in clinical trials. Pharm Med. 1988, 3: 349-359.
Metadata
Title
Use of randomisation in clinical trials: a survey of UK practice
Authors
Gladys C McPherson
Marion K Campbell
Diana R Elbourne
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Trials / Issue 1/2012
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-13-198

Other articles of this Issue 1/2012

Trials 1/2012 Go to the issue